-
Loading metrics
Efficacy of liquid biopsy for disease monitoring and early prediction of tumor progression in EGFR mutation-positive non-small cell lung cancer
- Hsiang-Ling Ho ,
- Yuqiu Jiang ,
- Chi-Lu Chiang,
- Sylwia Karwowska,
- Ranga Yerram,
- Keerti Sharma,
- Sidney Scudder,
- Chao-Hua Chiu,
- Chun-Ming Tsai,
- John F. Palma,
-
Abha Sharma ,
Contributed equally to this work with: Hsiang-Ling Ho, Yuqiu Jiang, Abha Sharma, Teh-Ying Chou
Roles Supervision, Writing – review & editing
* E-mail: abha.sharma@roche.com (AS); tehying@gmail.com (TYC)
Affiliation Clinical Development and Medical Affairs, Roche Diagnostic Solutions, Pleasanton, California, United States of America
⨯ - Teh-Ying Chou
https://orcid.org/0000-0001-9520-699X
Efficacy of liquid biopsy for disease monitoring and early prediction of tumor progression in EGFR mutation-positive non-small cell lung cancer
- Hsiang-Ling Ho,
- Yuqiu Jiang,
- Chi-Lu Chiang,
- Sylwia Karwowska,
- Ranga Yerram,
- Keerti Sharma,
- Sidney Scudder,
- Chao-Hua Chiu,
- Chun-Ming Tsai,
- John F. Palma
x
- Published: April 28, 2022
- https://doi.org/10.1371/journal.pone.0267362